Maithri Drugs: Dedicated to your API needs.

Reset all filters
01 1Maithri Drugs
02 1Baran Chemical and Pharmaceutical
03 1Bayer AG
04 1Chongqing Carelife Pharmaceutical
05 1Fuan Pharmaceutical
06 1Hetero Drugs
07 1Jinan Tantu Chemicals
08 2MSN Laboratories
09 1Natco Pharma
10 1Parsian Pharamceutical
11 1Sai Phytoceuticals
12 1Shandong Anhong Pharmaceutical
13 2Shouyuan Chemical
14 1Sichuan Kelun Pharmaceutical
15 1Sterling Spa
16 1Teva Pharmaceutical Industries
17 1Viatris
18 1Yangtze River Pharmaceutical Group
19 1Zhejiang Huayi Pharmaceutical Co., Ltd.
20 1Zhejiang Tianyu Pharmaceutical Co., Ltd
Reset all filters
01 10China
02 1Germany
03 6India
04 2Iran
05 1Israel
06 1Italy
07 1U.S.A
Reset all filters
01 8Active
02 14Blank
01 1Valid
02 21Blank
Reset all filters
01 22Blank
Reset all filters
01 1WC-0041
02 1WC-014
03 2WC-0349
04 18Blank
Reset all filters
01 1Su2420-5-ND
02 1Su434-45-ND
03 1Su758-2-ND
04 19Blank
Reset all filters
01 112527-0181
02 154893-0033
03 154893-0121
04 168554-0092
05 18Blank
01 22Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 42842
Submission : 2025-10-27
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2016-07-06
Pay. Date : 2016-05-02
DMF Number : 30490
Submission : 2016-05-13
Status : Active
Type : II
Date of Issue : 2025-09-03
Valid Till : 2028-08-08
Written Confirmation Number : WC-0041
Address of the Firm :
NDC Package Code : 68554-0092
Start Marketing Date : 2012-09-27
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2023-08-14
Pay. Date : 2023-05-08
DMF Number : 38197
Submission : 2023-04-26
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41290
Submission : 2025-02-09
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2025-11-07
Pay. Date : 2025-09-08
DMF Number : 41596
Submission : 2025-09-28
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39898
Submission : 2024-04-27
Status : Active
Type : II


Date of Issue : 2025-06-30
Valid Till : 2028-06-22
Written Confirmation Number : WC-014
Address of the Firm :
Registrant Name : Clasia Co., Ltd.
Registration Date : 2019-05-29
Registration Number : Su758-2-ND
Manufacturer Name : Natco Pharma Limited
Manufacturer Address : Chemical Division Mekaguda Village Nandigama Mandal Rangareddy District, Telangana, India


42
PharmaCompass offers a list of Regorafenib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Regorafenib manufacturer or Regorafenib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Regorafenib manufacturer or Regorafenib supplier.
A Regorafenib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Regorafenib, including repackagers and relabelers. The FDA regulates Regorafenib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Regorafenib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Regorafenib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Regorafenib supplier is an individual or a company that provides Regorafenib active pharmaceutical ingredient (API) or Regorafenib finished formulations upon request. The Regorafenib suppliers may include Regorafenib API manufacturers, exporters, distributors and traders.
click here to find a list of Regorafenib suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
We have 20 companies offering Regorafenib
Get in contact with the supplier of your choice: